(Q43127539)

14 November 2017

title

Valsartan increases circulating adiponectin levels without changing HOMA-IR in patients with type 2 diabetes mellitus and hypertension (English)

1 reference

14 November 2017

1 reference

J-M Lee

1

1 reference

14 November 2017

J-H Kim

2

1 reference

14 November 2017

H-S Son

3

1 reference

14 November 2017

E-G Hong

4

1 reference

14 November 2017

J-M Yu

5

1 reference

14 November 2017

K-A Han

6

1 reference

14 November 2017

K-W Min

7

1 reference

14 November 2017

S-A Chang

8

1 reference

14 November 2017

language of work or name

1 reference

1 January 2010

1 reference

Journal of International Medical Research

14 November 2017

published in

1 reference

14 November 2017

volume

38

1 reference

14 November 2017

issue

1

1 reference

14 November 2017

page(s)

234-241

1 reference

ACRP30/adiponectin: an adipokine regulating glucose and lipid metabolism

14 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F147323001003800128

Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323001003800128

Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323001003800128

Adiponectin: a key adipocytokine in metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323001003800128

The effects of valsartan on insulin sensitivity in patients with primary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323001003800128

Blockade of the renin-angiotensin system increases adiponectin concentrations in patients with essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323001003800128

The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure<SUBTITLE>The JNC 7 Report</SUBTITLE>

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323001003800128

The use of insulin secretagogues in the treatment of type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323001003800128

Telmisartan reduced blood pressure and HOMA-IR with increasing plasma leptin level in hypertensive and type 2 diabetic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323001003800128

Insulin sensitivity and endothelial function in hypertension: a comparison of temocapril and candesartan

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323001003800128

Blockade of sympathetic nervous system activity by rilmenidine increases plasma adiponectin concentration in patients with essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323001003800128

Anti-inflammatory and metabolic effects of candesartan in hypertensive patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323001003800128

Effects of telmisartan and ramipril on adiponectin and blood pressure in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323001003800128

Comparative effects of nebivolol and metoprolol on oxidative stress, insulin resistance, plasma adiponectin and soluble P-selectin levels in hypertensive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323001003800128

Mature adipocytes inhibit in vitro differentiation of human preadipocytes via angiotensin type 1 receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323001003800128

Effects of angiotensin II on adipose conversion and expression of genes of the renin-angiotensin system in human preadipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323001003800128

Angiotensin II receptor blocker valsartan suppresses reactive oxygen species generation in leukocytes, nuclear factor-kappa B, in mononuclear cells of normal subjects: evidence of an antiinflammatory action

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323001003800128

Effect of valsartan on monocyte/endothelial cell activation markers and adiponectin in hypertensive patients with type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323001003800128

10.1177/147323001003800128

21 January 2018

Identifiers

DOI

1 reference

14 November 2017

1 reference